Nextgen Healthcare Stock Revenue
| NXGNDelisted Stock | USD 23.94 0.00 0.00% |
Nextgen Healthcare fundamentals help investors to digest information that contributes to Nextgen Healthcare's financial success or failures. It also enables traders to predict the movement of Nextgen Stock. The fundamental analysis module provides a way to measure Nextgen Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nextgen Healthcare stock.
Nextgen |
Nextgen Healthcare Company Revenue Analysis
Nextgen Healthcare's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Nextgen Healthcare Revenue | 653.17 M |
Most of Nextgen Healthcare's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nextgen Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Nextgen Healthcare reported 653.17 M of revenue. This is 91.44% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 93.08% higher than that of the company.
Nextgen Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nextgen Healthcare's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nextgen Healthcare could also be used in its relative valuation, which is a method of valuing Nextgen Healthcare by comparing valuation metrics of similar companies.Nextgen Healthcare is currently under evaluation in revenue category among related companies.
Nextgen Fundamentals
| Return On Equity | -0.0144 | |||
| Return On Asset | 0.038 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 1.68 B | |||
| Shares Outstanding | 67.1 M | |||
| Shares Owned By Insiders | 33.55 % | |||
| Shares Owned By Institutions | 81.43 % | |||
| Number Of Shares Shorted | 4.84 M | |||
| Price To Earning | 253.66 X | |||
| Price To Book | 2.93 X | |||
| Price To Sales | 2.10 X | |||
| Revenue | 653.17 M | |||
| Gross Profit | 332.83 M | |||
| EBITDA | 52.93 M | |||
| Net Income | (2.65 M) | |||
| Cash And Equivalents | 70.73 M | |||
| Cash Per Share | 1.05 X | |||
| Total Debt | 274.76 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 1.29 X | |||
| Book Value Per Share | 6.31 X | |||
| Cash Flow From Operations | 43.66 M | |||
| Short Ratio | 6.60 X | |||
| Earnings Per Share | (0.09) X | |||
| Price To Earnings To Growth | 2.56 X | |||
| Target Price | 23.96 | |||
| Number Of Employees | 2.78 K | |||
| Beta | 0.77 | |||
| Market Capitalization | 1.61 B | |||
| Total Asset | 896.1 M | |||
| Retained Earnings | 127.6 M | |||
| Working Capital | 203.71 M | |||
| Current Asset | 101.06 M | |||
| Current Liabilities | 46.08 M | |||
| Z Score | 4.9 | |||
| Annual Yield | 0.05 % | |||
| Net Asset | 896.1 M |
About Nextgen Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nextgen Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nextgen Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nextgen Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Nextgen Healthcare information on this page should be used as a complementary analysis to other Nextgen Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Nextgen Stock
If you are still planning to invest in Nextgen Healthcare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nextgen Healthcare's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |